$32 million to kickstart European project investigating hypoglycemia

As part of a new European research project called Hypo-RESOLVE, a collection of more than 20 groups from academia, industry and civil society have joined forces to investigate solutions to alleviate the burden and consequences of hypoglycemia in diabetes.

The group is supported with funding of 26.8 million euros ($32 million) from the Innovative Medicines Initiative (IMI), a European Union and industry-backed group.

The project aims to provide researchers and clinicians with more validated data concerning the condition, which is still poorly understood by medical science.